Cisplatin oxaliplatin

Author: ysnm

August undefined, 2024

WebChemotherapy regimens included 5-fluorouracil (5-FU) in combination with interferon (n = 2 from Japan), cisplatin alone or in combination with 5-FU and other drugs (n = 4 from Japan and n = 1 from Korea), 5-FU and oxaliplatin (n = 2 from China), and 5-FU, cisplatin, leucovorin, and epirubicin (n = 1 from China). The OS ranged from 33.2 to 56.4 ... WebMar 3, 2024 · Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell ...

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

WebJun 3, 2024 · While S-1 plus cisplatin is the standard first-line treatment for patients with advanced gastric cancer in Asia, recent studies have indicated that oxaliplatin-based … WebApr 11, 2024 · The effects of oxaliplatin on membrane CLDN1 expression were evaluated by flow cytometry, immunofluorescence and western blotting experiments in vitro and in vivo. Phosphoproteome analyses, proximity ligation and luciferase reporter assays were used to unravel the mechanism of CLDN1 induction. ... Moreover, it promotes cisplatin … dakota first nations

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the …

WebMay 20, 2010 · Oxaliplatin [ [ (1 R ,2 R )-cyclohexane-1,2-diamine] (ethanedioate- O, 𝑂 )platinum (II)] is a third-generation platinum compound widely used for the treatment of metastatic colorectal cancer and a variety of other malignancies, such as breast cancer, melanoma, non-Hodgkin lymphoma, and head and neck cancer [ 23 – 25 ]. WebDoes resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA) ... (S-1 + cisplatin) had no survival advantage compared to the continuous chemotherapy group, with median OS times of 14.3 ... WebMay 23, 2024 · cisplatin as front-line treatment for ovarian cancer. It is currently approved by FDA for use in the treatment of advanced ovarian and lung cancer in combination with paclitaxel or cyclophosphamide [5]. Oxaliplatin (Figure 1) is the most recent drug approved by FDA in 2002. It exhibits a dakota fleece lined duck jac shirt

Platinum Compounds - an overview ScienceDirect Topics

NCBI Bookshelf

WebSystemic cisplatin and oxaliplatin induced similar tumor growth delay when combined with anti-PD-1 therapy. Conclusions: Treatment of HNSCC cells with platinum chemotherapy appears to induce some features of anti-tumor immunity, which may be … WebResults: Cisplatin-induced neuropathy was more similar to neuropathy in patients receiving oxaliplatin than in those receiving paclitaxel. The cisplatin and oxaliplatin groups exhibited the coasting phenomenon and more prominent upper extremity symptoms than lower extremity symptoms during chemotherapy administration weeks. biotic conditionsWebOxaliplatin is used to treat colon or rectal cancer that has spread (metastasized), it is often given in combination with other anticancer drugs (fluorouracil and leucovorin). Note: If a drug has been approved for one use, physicians sometimes elect to use this same drug for other problems if they believe it might be helpful. dakota floating goose decoys

"WebAs compared with cisplatin, oxaliplatin was associated with significantly less grade 3 or 4 neutropenia and alopecia but significantly more grade 3 or 4 diarrhea and peripheral neuropathy. Grade... " - Cisplatin oxaliplatin

Cisplatin oxaliplatin

Gastric cancer: Oxaliplatin and cisplatin confer similar survival in ...

WebCisplatin is a chemotherapy medication used to treat a number of cancers. [2] These include testicular cancer, ovarian cancer, cervical cancer, bladder cancer, head and neck cancer, esophageal cancer, lung cancer, mesothelioma, brain tumors and neuroblastoma. [2] It is given by injection into a vein. [2] WebOxaliplatin is a third-generation platinum compound that has shown a wide range of anti-tumour activity in metastatic cancer and in multiple cell lines. It contains a diaminocyclohexane carrier ligand and is one of the least …

Did you know?

WebOct 5, 2014 · Cisplatin and oxaliplatin in combination with quercetin and thymoquinone in human ovarian tumour models is the best combination to treat ovarian cancer (Nessa, … WebBackground: Cisplatin has been largely used in the treatment of advanced, unresectable gastric cancer, mainly in combinations with fluoropyrimidines and anthracyclines. …

Webcisplatin (Rx) Brand and Other Names: Classes: Antineoplastics, Alkylating; Antineoplastics, Platinum Analog Print Dosing & Uses AdultPediatricGeriatric Dosage Forms & Strengths injectable... WebWe investigated the activity and safety of first-line GEMOX compared with gemcitabine–carboplatin (GCb) in cisplatin-ineligible patients with advanced UCC. Methods: Treatment-naive, cisplatin-ineligible patients with advanced UCC were randomly assigned to GEMOX (gemcitabine 1000 mg/m 2 , oxaliplatin 100 mg/m 2 on day 1 [D1] …

WebJul 22, 2024 · Cisplatin is a potent and valuable chemotherapy agent used to treat a broad spectrum of malignancies. Renal tubular dysfunction and a cumulative impairment in kidney function, as manifested by a decline in the glomerular filtration rate (GFR), can be … WebCisplatin is known to produce significant toxicity to both the CNS and PNS, in a cumulative and dose-dependent manner. Carboplatin and oxaliplatin can produce a similar spectrum of neurological toxicities, but to a much lesser extent. The most frequent neurotoxic side-effects of cisplatin involve the PNS (see Chapter 60 ).

WebPlatinum-based drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of human neoplasms. Their clinical success is, however, limited due to severe side effects and intrinsic or acquired resistance to the treatment. Much effort has been put into the development of new platinum a … Platinum-based drugs: past, present and future

http://mdedge.ma1.medscape.com/hematology-oncology/article/254817/gastrointestinal-cancer/gastric-cancer-oxaliplatin-and-cisplatin biotic diversityWebJun 15, 2024 · We could not detect survival differences between patients treated with cisplatin versus oxaliplatin. Diarrhea more frequently impacted patients treated with oxaliplatin than patients treated with cisplatin. As hydration is not needed for oxaliplatin, it is more practical to use in daily care. dakota flannel jacket with hoodWebJan 8, 2024 · Cisplatin, carboplatin, and oxaliplatin are the common platinum-based anticancer drugs widely used in the chemotherapeutic treatment of solid tumors in clinic. However, the comprehensive pharmacokinetics of platinum-based anticancer drugs has not been fully understood yet. biotic diversity definitionWebMay 22, 2024 · Gastric cancer: Oxaliplatin and cisplatin confer similar survival in elderly patients. Publish date: May 22, 2024. Clinical Edge Journal Scan: Gastric Cancer June 2024 (4 of 11) Commentary: Gastric Cancer Chemotherapy in Select Populations, June 2024; dakota flooring \\u0026 acoustics bismarckWebThe microarray data sets for cisplatin- and oxaliplatin-treated A2780 human ovarian cancer cells (GSE8057 ) were obtained from the NCBI GEO database. GSEA was performed for the enrichment of 50 cancer hallmarks. The common and specific cancer hallmarks for cisplatin and oxaliplatin are shown in a Venn diagram (Figure 3A). We … biotic disease definitionWebFeb 5, 2024 · Cisplatin and Oxaliplatin: Our Current Understanding of Their Actions. Following the serendipitous discovery of the anticancer activity of cisplatin over 50 years ago, a deep understanding of the chemical and biochemical transformations giving rise … biotic definition in scienceWebWe investigated the activity and safety of first-line GEMOX compared with gemcitabine–carboplatin (GCb) in cisplatin-ineligible patients with advanced UCC. … biotic ear drops